Common Contracts
4 similar Share Subscription Agreement contracts by RVL Pharmaceuticals PLC
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Share Subscription Agreement (this “Agreement”) is dated as of August 4, 2022 (the “Effective Date”), by and between RVL Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Avista Healthcare Partners, L.P., a Bermuda limited partnership (the “Purchaser”).
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Share Subscription Agreement (this “Agreement”) is dated as of August 4, 2022 (the “Effective Date”), by and between RVL Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Athyrium Opportunities IV Co-Invest 2 LP, a Delaware limited partnership (the “Purchaser”).
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Share Subscription Agreement (this “Agreement”) is dated as of August 4, 2022 (the “Effective Date”), by and between RVL Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Brian Markison (the “Purchaser”).
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Share Subscription Agreement (this “Agreement”) is dated as of August 4, 2022 (the “Effective Date”), by and between RVL Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (the “Company”), and James Schaub (the “Purchaser”).
